Krystal Biotech, Inc. (KRYS) Cash Flow Statement

The ratio above 1.0x in seven of the ten reported quarters suggests non-cash charges, including stock-based compensation and depreciation, are a meaningful contributor to cash generation. The 2025Q3 reading, where operating cash flow fell to $39.7M against $79.4M of net income, appears driven by working capital movements rather than operations, and investors should monitor whether the gap reflects timing or a structural earnings quality issue.

Capital expenditure remains minimal relative to revenue, so FCF margin tracks operating cash flow closely, which suggests the margin expansion reflects operating leverage on a largely fixed cost base. The sustained profile in recent quarters implies the business is now self-funding, though the lower margin in 2025Q1 at 28.1% shows the trajectory has not been linear.

The magnitude of these swings relative to quarterly net income suggests the company's cash conversion is more sensitive to collection timing and gross-to-net adjustments than to core profitability. Investors should monitor receivable aging and payer reimbursement cycles, since large reversals may indicate that reported quarterly cash strength partly reflects timing rather than sustained collections.

Depreciation of roughly $1.6M per quarter against capex that is frequently lower indicates the asset base is being maintained at a low replacement rate, which supports high free cash flow conversion. The spike to 7.0% in 2025Q1 may reflect facility-related investment, and whether manufacturing scale-up requires higher capex in future periods warrants further investigation.

The absence of dividends combined with minimal repurchases suggests management is prioritizing balance sheet optionality over capital returns, which aligns with a company still building its commercial and pipeline position. The 2026Q1 buyback is the only meaningful deployment, and investors should watch whether future allocation shifts toward acquisitions, pipeline spending, or repurchases as cash balances grow.